Travelers Companies TRV has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 5 | 6 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 1 | 1 | 0 | 0 |
3M Ago | 0 | 4 | 4 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $275.45, a high estimate of $303.00, and a low estimate of $247.00. Observing a 2.47% increase, the current average has risen from the previous average price target of $268.82.
Analyzing Analyst Ratings: A Detailed Breakdown
The standing of Travelers Companies among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Alex Scott | Barclays | Lowers | Equal-Weight | $274.00 | $280.00 |
Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $303.00 | $290.00 |
Michael Phillips | Morgan Stanley | Raises | Equal-Weight | $269.00 | $245.00 |
Elyse Greenspan | Wells Fargo | Raises | Equal-Weight | $260.00 | $247.00 |
David Motemaden | Evercore ISI Group | Raises | Outperform | $296.00 | $288.00 |
Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $290.00 | $274.00 |
Alex Scott | Barclays | Lowers | Overweight | $280.00 | $287.00 |
Yaron Kinar | Jefferies | Raises | Hold | $270.00 | $265.00 |
Brian Meredith | UBS | Lowers | Neutral | $267.00 | $270.00 |
Meyer Shields | Keefe, Bruyette & Woods | Lowers | Outperform | $274.00 | $286.00 |
Elyse Greenspan | Wells Fargo | Raises | Equal-Weight | $247.00 | $225.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Travelers Companies. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Travelers Companies compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Travelers Companies's stock. This comparison reveals trends in analysts' expectations over time.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Travelers Companies's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Travelers Companies analyst ratings.
Get to Know Travelers Companies Better
Travelers offers a broad product range and participates in both commercial and personal insurance lines. Its commercial operations offer a variety of coverage types for companies of any size but concentrate on serving midsize businesses. Its personal lines are roughly evenly split between auto and homeowners insurance.
A Deep Dive into Travelers Companies's Financials
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Travelers Companies's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 5.18%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 3.32%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Travelers Companies's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.4%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Travelers Companies's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.29%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.28, Travelers Companies adopts a prudent financial strategy, indicating a balanced approach to debt management.
The Basics of Analyst Ratings
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|